An elderly, nondiabetic, chronic hemodialysis patient is described here who had profound hypoglycemia for a myriad of reasons including renal failure, malnutrition, and quinine use. Furthermore, by biochemical parameters the patient had hyperinsulinemia, which was consistent with the diagnosis of an insulinoma. However, a tumor was not identified by noninvasive radiologic imaging as is often the case and the patient was not a candidate for surgical exploration. Diazoxide at a dose of 225 mg/day was used to successfully manage this patient’s hypoglycemia. Previous experience with the use of diazoxide for hyperinsulinism in the hemodialysis population is limited and this case is the second report of its use for this purpose.

Keywords:
Diazoxide, Hypoglycemia, Hyperinsulinemia, Renal failure
1.
Fischer KF, Lees JA, Newman JH: Hypoglycemia in hospitalized patients. N Engl J Med 1986;315:1245–1250.
2.
Arem R: Hypoglycemia associated with renal failure. Endocrinol Metab Clin N Am 1989;18:103–121.
3.
Nadkarni M, Berns JS, Rudnick MR, Cohen RM: Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy. Nephron 1992;60:100–103.
4.
Garber AJ, Bier DM, Cryer PE, Pagliara AS: Hypoglycemia in compensated chronic renal insufficiency. Diabetes 1974;23:982–986.
5.
Block MB, Rubenstein AH: Spontaneous hypoglycemia in diabetic patients with renal insufficiency. JAMA 1970;213:1863–1866.
6.
Frizzell M, Larsen PR, Field JB: Spontaneous hypoglycemia associated with chronic renal failure. Diabetes 1973;22:493–498.
7.
Peitzman SJ, Agarwal BN: Spontaneous hypoglycemia in end-stage renal failure. Nephron 1977;19:131–139.
8.
Rabau M, Dor J, Adar R, Walden R, Mozes M: Spontaneous hypoglycemia in a diabetic patient with renal failure. Isr J Med 1973;9:1036–1039.
9.
Bansal VK, Brooks MH, York JC, Hano JE: Intractable hypoglycemia in a patient with renal failure. Arch Intern Med 1979;139:100–102.
10.
Rutsky EA, McDaniel HG, Tharpe DI, Alred G, Pek S: Spontaneous hypoglycemia in chronic renal failure. Arch Intern Med 1978;138:1364–1366.
11.
White MG, Kurtzman NA: Hypoglycemia in diabetics with renal insufficiency. JAMA 1971;215:117.
12.
Rabkin R, Simon NM, Steiner S, Colwell JA: Effect of renal disease on renal uptake and excretion of insulin in man. N Engl J Med 1976;282:182–187.
13.
White NJ, Warrell DA, Chanthavanich P, Looareesuwan N, Warrell MJ, Krishna S, Williamson DH, Turner RC: Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983;309:61–66.
14.
Harats N, Ackerman Z, Shalit M: Qunine-related hypoglycemia. N Engl J Med 1984;310:1331.
15.
Fajans SS, Vinik AI: Insulin-producing islet cell tumors. Endocrinol Metab Clin N Am 1989;18:45–75.
16.
King CMP, Reznek RH, Dacie JE, Wass JAH: Imaging islet cell tumours. Clin Radiol 1994;49:295–303.
17.
Jensen RT, Norton JA: Endocrine tumors of the pancreas; in Sleisinger MH, Fordtran JS (eds): Gastrointestinal Disease Pathophysiology, Diagnosis, Management, ed 5. Philadelphia, Saunders, 1993, pp 1698–1702.
18.
Doherty GM, Doppman JL, Shawker TH, Miller DL, Eastman RC, Gorden P, Norton JA: Results of a prospective strategy to diagnose, localize, and resect insulinomas. Surgery 1991;110:989–997.
19.
Schumacher B, Lubke HJ, Strohnmeyer G, Starke AAR: Prospective study on the detection of insulinomas by endoscopic ultrasound. Endoscopy 1996;28:273–276.
20.
Rosch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV, Yasuda K, Heyder N, Palazzo L, Dancygier H, Schusdziarra V, Classen M: Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992;326:1721–1726.
21.
Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, Coilier E, Skarulis MC, Gorden P: Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med 1995;123:269–273.
22.
Stefanini P, Carboni M, Patrassi N, Basoli A: Beta-islet cell tumors of the pancreas: Results of a study on 1067 cases. Surgery 1974;75:597–609.
23.
Goode PN, Farndon JR, Anderson J, Johnston IDA, Abascal Morte J: Diazoxide in the management of patients with insulinoma. World J Surg 1986;10:586–592.
24.
Anonymous: Diazoxide. Br Med J 1972;iv:417–418.
25.
Gill GV, Rauf O, MacFarlane IA: Diazoxide treatment for insulinoma: A national UK survey. Postgrad Med J 1997;73:640–641.
26.
Stefanini P, Carboni M, Patrassi N, De Bernardinis G, Negro P: Problems of the management of insulinomas: Review of 132 cases treated with medical measures. Acta Diabet Lat 1974;11:71–77.
27.
Wegienka LC, Simpson RG, Karam JH, Forsham PH: Clinical experience with diazoxide. Ann NY Acad Sci 1968;150:383–394.
28.
Graber AL, Porte D, Williams RH: Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man. Ann NY Acad Sci 1968;150:303–308.
29.
Marks V, Samols E: Diazoxide therapy of intractable hypoglycemia. Ann NY Acad Sci 1968;150:442–454.
30.
Tabachnick II, Gulbenkian A: Mechanism of diazoxide hyperglycemia in animals. Ann NY Acad Sci 1968;150:204–218.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.